High IL-6 in military personnel relates to multiple traumatic brain injuries and post-traumatic stress disorder.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
17 08 2020
Historique:
received: 19 08 2019
revised: 04 03 2020
accepted: 15 05 2020
pubmed: 30 5 2020
medline: 14 10 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Repetitive traumatic brain injuries (TBIs) among military personnel have been linked to chronic behavioral and neurological symptoms, and poor health outcomes. Repetitive TBIs may impact inflammation, which may offer some explanation of the biological basis of these long-term risks, and may improve the care that is provided to these individuals. This study examines the concentrations of TNFα, IL-6 and IL-10 and associations with behavioral symptoms, including post-traumatic stress disorder symptoms and depression in a cohort of 106 military personnel and Veterans with a history of TBI. Group comparisons conducted for those with repetitive TBIs (> 3; n = 44), to participants with less than three TBIs (n = 29), and controls with no TBIs (n = 33). The primary outcomes were serum levels of inflammatory related proteins TNF-α, IL-6 and IL-10, TBI history, and PTSD symptoms. IL-6 mean concentration was significantly higher in the repetitive TBI group compared to those with 1-2 TBI or no TBI history (p = 0.050). Additionally, for participants with a history of TBI, PTSD symptom severity, specifically, intrusion (p = .006 and p = .007) and avoidance (p = .034 and .009), were significant predictors of higher IL-6 and IL-10 concentrations respectively. These findings suggest that repetitive TBIs concurrent with high PTSD symptoms in military personnel and Veterans are associated with chronic inflammation, and specifically elevated concentrations of IL-6. Examining the changes in inflammatory processes may identify potential therapeutic targets for early intervention after TBI in order to prevent the development of neurological deficits and disorders.

Identifiants

pubmed: 32470481
pii: S0166-4328(20)30414-9
doi: 10.1016/j.bbr.2020.112715
pii:
doi:

Substances chimiques

IL10 protein, human 0
IL6 protein, human 0
Interleukin-6 0
Tumor Necrosis Factor-alpha 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112715

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Tamar Rodney (T)

John Hopkins University, School of Nursing, 525 N. Wolfe Street, Baltimore, MD, 21205, USA. Electronic address: trodney1@jhu.edu.

Patricia Taylor (P)

Henry M. Jackson Foundation, 6720A Rockledge Drive, Bethesda, MD, 20817, USA; Center for Neuroscience and Regenerative Medicine, 12725 Twinbrook Parkway, Rockville, MD, 20852, USA.

Kerri Dunbar (K)

Henry M. Jackson Foundation, 6720A Rockledge Drive, Bethesda, MD, 20817, USA; Center for Neuroscience and Regenerative Medicine, 12725 Twinbrook Parkway, Rockville, MD, 20852, USA.

Nancy Perrin (N)

John Hopkins University, School of Nursing, 525 N. Wolfe Street, Baltimore, MD, 21205, USA.

Chen Lai (C)

National Institutes of Health, National Institute of Nursing Research, 9000 Rockville Pike, Bethesda, MD, 20892, USA.

Michael Roy (M)

Center for Neuroscience and Regenerative Medicine, 12725 Twinbrook Parkway, Rockville, MD, 20852, USA; Uniformed Services University of the Health Sciences, Department of Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA.

Jessica Gill (J)

National Institutes of Health, National Institute of Nursing Research, 9000 Rockville Pike, Bethesda, MD, 20892, USA; Center for Neuroscience and Regenerative Medicine, 12725 Twinbrook Parkway, Rockville, MD, 20852, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH